Cureteq is an asset management and biotechnology company - enabled by artificial intelligence (AI).
The cureteq platform has three main components: First, leveraging AI and data insights to in license drug candidates from pharmaceutical companies and biotech to unlock hidden value, e.g. assets that have gone under-prioritized or with promising data but outside company strategy. Further utilize AI in devising accelerated, optimized and de-risked clinical development programs. Second, an ecosystem of connected, yet independent, subsidiaries with each their disease area focus and leading the drug development of acquired assets; this secures agile and nimble drug development while retaining economies of scale and broader access to competences and resources as known from larger organizations. Finally, and third, flexibility around financing and partnering for each asset and subsidiary - patterning can be tailored to match the specific needs of asset, partners and investors.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Baarerstrasse 18, Zug,zg 6300,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cureteq.com
- HQ
- Zug, ZG
Cureteq Ag - A Partex Company Questions
Cureteq Ag - A Partex Company's website is http://www.cureteq.com
Cureteq Ag - A Partex Company's LinkedIn profile is https://ch.linkedin.com/company/cureteq
Cureteq Ag - A Partex Company has
4 employees.
View email and phone details for 4
employees at Cureteq Ag - A Partex Company.
Cureteq Ag - A Partex Company's industry is
Biotechnology Research
Cureteq Ag - A Partex Company's top competitors are
Amrit - A Partex Company,
Assay.works - A Partex Company,
Debiopharm,
Sachs Associates,
Innoplexus - A Partex Company,
Curateq Biologics,
Swiss Hlg,
Cdr-Life Inc.,
Perpetual Block - A Partex Company,
Partex.
Cureteq Ag - A Partex Company's categories are Biotechnology Research
Cureteq Ag - A Partex Company's founding year is 2021
